1 However, it is recommended to avoid use in patients with a personal or family history of MTC and in patients with multiple neoplasia syndrome type 2
However, there have not been sufficient clinical studies to show safety and efficacy in other parts of the body
455 An uncontrolled preliminary trial showed 1.3 grams of nattokinase three times daily with meals for eight days enhanced the fibrinolytic activity and fibrin breakdown product levels in blood samples from seven subjects
Users are responsible for: Verifying their own licensure and authorization to purchase this product Understanding and complying with all federal, state, and local regulations governing pharmaceutical use and handling Following proper aseptic technique and institutional protocols Seeking appropriate medical or pharmaceutical guidance for clinical questions Mountainside Medical disclaims liability for injury, infection, or adverse outcomes resulting from improper use, storage, handling, or violation of aseptic technique by users or institutions
Current Issues in Molecular Biology, 45 (2), 17621778